Gyre Therapeutics

GYRE · NASDAQ

$6.17+$0.08 (+1.31%)TodayMarket closed ·
Prev close $6.09

Who owns GYRE

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 94.2% of GYRE’s shares.

  • GNI Group Ltd79.6%
  • HSG Holding Ltd.4.1%
  • Ma (Songjiang)3.1%
  • Luo (Ying)2.8%
  • Next 6 largest institutions4.6%
  • All other shareholders5.8%
Top institutional holders of GYRE
HolderShares% of shares
GNI Group Ltd72.77M79.65%
HSG Holding Ltd.3.75M4.10%
Ma (Songjiang)2.81M3.07%
Luo (Ying)2.58M2.82%
Octagon Capital Advisors LP954.42K1.04%
BlackRock Institutional Trust Company, N.A.893.56K0.98%
Vanguard Capital Management, LLC876.93K0.96%
Ye (Weiguo)700.00K0.77%
Geode Capital Management, L.L.C.532.95K0.58%
State Street Investment Management (US)245.40K0.27%

Largest mutual fund holders

Top mutual fund holders of GYRE
HolderShares% of shares
Vanguard Total Stock Market Index Fund614.65K0.67%
iShares Russell 2000 ETF392.63K0.43%
Vanguard Extended Market Index Fund238.69K0.26%
Fidelity Small Cap Index Fund200.15K0.22%
iShares Russell 2000 Growth ETF121.65K0.13%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $952.87K (18 trades) of GYRE on the open market, with no buys.

Latest GYRE insider transactions
InsiderTypeSharesValue
Weston ClaireAward40.00K—
Kirkby MaxwellAward40.00K—
Ye WeiguoOption exercise3.00K—
Ye WeiguoSale3.00K$19.05K
Ye WeiguoOption exercise3.00K$2.25K
Ye WeiguoOption exercise2.80K—
Ye WeiguoSale2.80K$17.28K
Ye WeiguoOption exercise2.80K$2.10K
Ye WeiguoOption exercise5.00K—
Ye WeiguoSale5.00K$31.20K

Short interest

Settled Sep 30, 2026

Shares short
1.92M
Days to cover
6.92
% of shares outstanding
2.10%
Average daily volume
277.12K
Change since last report
+10.9%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.